Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bendamustine hydrochloride - Slayback Pharma

Next Previous
Drug Profile

Bendamustine hydrochloride - Slayback Pharma

Alternative Names: Bendamustine hydrochloride injection - Slayback Pharma; VIVIMUSTA

Latest Information Update: 19 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Slayback Pharma
  • Class Antineoplastics; Benzimidazoles; Butyric acids; Nitrogen mustard compounds; Nitrosourea compounds; Small molecules
  • Mechanism of Action Alkylating agents; Antimetabolites; DNA cross linking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Chronic lymphocytic leukaemia; Non-Hodgkin's lymphoma

Most Recent Events

  • 19 Dec 2025 Launched for Chronic lymphocytic leukaemia (Second-line therapy or greater) in USA (IV) before December 2025 (Azurity Pharmaceuticals website, December 2025)
  • 19 Dec 2025 Launched for Non-Hodgkin's lymphoma (Second-line therapy or greater) in USA (IV) before December 2025 (Azurity Pharmaceuticals website, December 2025)
  • 27 Sep 2023 Slayback Pharma has been acquired by Azurity Pharmaceuticals

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top